The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study

A. van Hylckama Vlieg; C.A. Baglin; R. Luddington; S. MacDonald; F.R. Rosendaal; T.P. BAGLIN

doi:10.1111/jth.13043

journal article Open Access Sep 01, 2015

The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study

A. van Hylckama Vlieg C.A. Baglin R. Luddington S. MacDonald F.R. Rosendaal T.P. BAGLIN

Journal of Thrombosis and Haemostasis Vol. 13 No. 9 pp. 1642-1652 · Elsevier BV

View at Publisher Save 10.1111/jth.13043

Topics

No keywords indexed for this article. Browse by subject →

References

25

[1]

Nordström "A prospective study of the incidence of deep‐vein thrombosis within a defined urban population" J Intern Med (1992) 10.1111/j.1365-2796.1992.tb00565.x

[2]

Anderson "A population‐based perspective of the hospital incidence and case‐fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study" Arch Intern Med (1991) 10.1001/archinte.1991.00400050081016

[3]

Naess "Incidence and mortality of venous thrombosis: a population‐based study" J Thromb Haemost (2007) 10.1111/j.1538-7836.2007.02450.x

[4]

Hansson "Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors" Arch Intern Med (2000) 10.1001/archinte.160.6.769

[5]

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

Paolo Prandoni, Anthonie W.A. Lensing, Alberto Cogo et al.

Annals of Internal Medicine 1996 10.7326/0003-4819-125-1-199607010-00001

[6]

Palareti "Bleeding complications of oral anticoagulant treatment: an inception‐cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy" Lancet (1996) 10.1016/s0140-6736(96)01109-9

[7]

Kearon "A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism" N Engl J Med (1999) 10.1056/nejm199903253401201

[8]

Tans "APC resistance determined with the endogenous thrombin generation potential is associated with venous thrombosis: a blinded clinical evaluation" Thromb Haemost (1999)

[9]

Tans "Activated protein C resistance determined with a thrombin generation‐based test predicts for venous thrombosis in men and women" Br J Haematol (2003) 10.1046/j.1365-2141.2003.04443.x

[10]

van Hylckama Vlieg "Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence" Br J Haematol (2007) 10.1111/j.1365-2141.2007.06738.x

[11]

Palareti "D‐dimer testing to determine the duration of anticoagulation therapy" N Engl J Med (2006) 10.1056/nejmoa054444

[12]

Verhovsek "Systematic review: D‐dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism" Ann Intern Med (2008) 10.7326/0003-4819-149-7-200810070-00008

[13]

Hron "Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation" JAMA (2006) 10.1001/jama.296.4.397

[14]

Besser "High rate of unprovoked recurrent venous thrombosis is associated with high thrombin‐generating potential in a prospective cohort study" J Thromb Haemost (2008) 10.1111/j.1538-7836.2008.03117.x

[15]

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

A. TOSETTO, A. Iorio, M. MARCUCCI et al.

Journal of Thrombosis and Haemostasis 2012 10.1111/j.1538-7836.2012.04735.x

[16]

Eichinger "Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model" Circulation (2010) 10.1161/circulationaha.109.925214

[17]

Rodger "Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy" CMAJ (2008) 10.1503/cmaj.080493

[18]

Luddington "Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition" J Thromb Haemost (2004) 10.1111/j.1538-7836.2004.00964.x

[19]

Dargaud "Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study" Thromb Res (2012) 10.1016/j.thromres.2012.07.017

[20]

Legnani "Different cut‐off values of quantitative D‐dimer methods to predict the risk of venous thromboembolism recurrence: a post‐hoc analysis of the PROLONG study" Haematologica (2008) 10.3324/haematol.12320

[21]

Kearon "D‐dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study" Ann Intern Med (2015) 10.7326/m14-1275

[22]

Kearon "Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines" Chest (2012) 10.1378/chest.11-2301

[23]

Cosmi "D‐dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep‐vein thrombosis" Thromb Haemost (2011) 10.1160/th10-08-0559

[24]

Eichinger "Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D‐dimer" Clin Chem (2008) 10.1373/clinchem.2008.112243

[25]

Eichinger "D‐dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model" J Am Heart Assoc (2014) 10.1161/jaha.113.000467

Cited By

78

External validation of the DASH prediction rule: a retrospective cohort study

A. TOSETTO, S. Testa · 2017

Journal of Thrombosis and Haemostas...

Metrics

78

Citations

25

References

Details

Published: Sep 01, 2015
Vol/Issue: 13(9)
Pages: 1642-1652
License: View

Authors

A

A. van Hylckama Vlieg

Funding

Netherlands Organization for Scientific Research Award: 916.56.157

Cite This Article

A. van Hylckama Vlieg, C.A. Baglin, R. Luddington, et al. (2015). The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study. Journal of Thrombosis and Haemostasis, 13(9), 1642-1652. https://doi.org/10.1111/jth.13043

The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study

You May Also Like